Discover investment opportunities in AI Medical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Medical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Medical Stocks using our Smart AI Filter.
10 stocks found for "AI Medical Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.62 Risk measure | ±33.1% Price volatility | 25.0 Valuation | 0.82% Annual yield | |||
0.49 Risk measure | ±19.6% Price volatility | 26.1 Valuation | 1.76% Annual yield | |||
0.92 Risk measure | ±51.9% Price volatility | 41.3 Valuation | 0.00% Annual yield | |||
1.92 Risk measure | ±85.0% Price volatility | -11.8 Valuation | 0.00% Annual yield | |||
1.77 Risk measure | ±71.4% Price volatility | -18.6 Valuation | 0.00% Annual yield | |||
0.64 Risk measure | ±28.2% Price volatility | 69.3 Valuation | 0.00% Annual yield | |||
1.50 Risk measure | ±64.8% Price volatility | -8.0 Valuation | 0.00% Annual yield | |||
1.19 Risk measure | ±53.7% Price volatility | -156.9 Valuation | 0.00% Annual yield | |||
1.02 Risk measure | ±49.1% Price volatility | 40.9 Valuation | 0.00% Annual yield | |||
0.36 Risk measure | ±21.7% Price volatility | 15.1 Valuation | 3.17% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
With retail sales rebounding and Wall Street gaining, low-leverage stocks like NVS, RMD, WAB, ESLT and INGR offer scope for upside.
Read moreAbbott (ABT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read moreBesides Wall Street's top-and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read moreCORT's relacorilant combo targets platinum-resistant ovarian cancer in new NDA, backed by positive ROSELLA study data.
Read moreNovoCure (NVCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Read moreGH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.
Read more